Nash Pharmaceuticals Announces 84% Reduction of Fibrosis by Additional Lead Compound In Second Pre-Clinical Study For Non-Alcoholic Fatty Liver Disease

VANCOUVER, British Columbia, Jan. 21, 2019 (GLOBE NEWSWIRE) — Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH)

Read more

Innovus Pharma Announces the Approval of the Product Licenses for Zestra®, Zestra Glide®, EjectDelay® and Sensum+® by the Indian FDA (Directorate General of Health Services) through its Partner Khandelwal Laboratories

SAN DIEGO (UPTICK Newswire – August 22nd, 2016) – Innovus Pharmaceuticals, Inc. (“Innovus Pharma”) (OTCQB Venture Market: INNV), an emerging commercial

Read more

Premier Biomedical Anti-Cancer Antibody Outperforms Leading Multi-Billion Dollar Commercial Cancer Treatments in Initial Head-to-Head Testing at a Major University

EL PASO, TX – (Uptick Newswire – July 6, 2016) – Premier Biomedical, Inc. (OTCQB: BIEI) announced today the favorable results

Read more